Spinal Surgery - Laminectomy and Fusion Policy
Customize your policy alerts
Sign up for mediviewcurative Policy MM-PNP-019 alerts
Get alerted when Policy MM-PNP-019 changes without checking for updates manually.
Monitor payer policy activity
Defines Curative's clinical, safety, and medical-necessity criteria and pre-operative requirements for spinal laminectomy and fusion procedures used in utilization review, pre-authorization, and clinical decision-making for Curative Medical UM operations.
Mandatory Pre-Surgical Optimization Program (P-SOP) required for all elective spinal fusion and for high-risk elective decompressions, including specific components and metrics.
Nicotine cessation requirement with objective testing: negative urine cotinine <100 ng/mL within 7 days of surgery; alternatives for NRT users.
Specific conservative management durations: 3-6 months for fusion indications and 6-12 weeks for laminectomy/decompression.
Explicit exclusions listing devices, procedures, and biologic therapies considered not medically necessary (e.g., interspinous devices, lumbar ADR, stem cell therapy, inconsistent BMP use).
Coverage and Medical Necessity Criteria
Elective surgery medical necessity
Covered when ALL of the following are met for elective fusion or for elective decompression in High-Risk Patients:
Instability must be documented by dynamic imaging per thresholds in policy.
Level-specific medical necessity
Level-specific criteria (examples):
Disc arthroplasty is covered for 1-2 level DDD without significant facet arthritis or instability.
Level-Specific & Advanced Techniques (Cervical, Thoracic, Lumbar)
Medical necessity for level-specific and advanced spinal surgical techniques is addressed in the policy (detailed criteria summarized or referenced below):
Full, detailed AND/OR logic and additional technique-specific criteria are contained in the policy sections and appendices referenced by this document.
The policy explicitly lists the following examples as exclusions (considered not medically necessary when performed outside the specified indications): Interspinous/interlaminar stabilization or decompression devices without fusion (for example, Coflex, X‑Stop, Superion); isolated facet fusion or arthroplasty (intrafacet implants) for isolated axial back pain; lumbar or thoracic total disc replacement (lumbar ADR and thoracic TDR); vertebral augmentation (vertebroplasty/kyphoplasty) for chronic non‑traumatic compression fractures > 3 months without non‑union; stem cell or PRP injections for disc regeneration, pain, or fusion enhancement; BMP use (e.g., rhBMP‑2/INFUSE) when inconsistent with FDA‑approved labeling (for example, most cervical fusions or lateral/multi‑level use); laminectomy/decompression for isolated axial pain without corresponding symptoms, instability, or deformity; and surgical fusion for degenerative disc disease (DDD) that lacks the required 12‑month conservative treatment and documented functional disability.
Some parts of the policy note that additional exclusion details and authoritative guidance are provided outside the main text. Appendix A and the referenced guideline sources are cited as the locations for mandatory patient safety requirements and supporting guidance; therefore, explicit exclusion language or additional examples may appear in those appendices or in the referenced documents rather than in the body of the policy.
Procedures and therapies listed in the exclusions section are designated in the policy as not medically necessary when used outside the specified indications. The document identifies the specific interventions (e.g., interspinous devices, isolated facet fusion, lumbar ADR, vertebral augmentation in chronic non‑union‑absent fractures, stem cell/PRP, inconsistent BMP use, and fusion for DDD without 12 months of conservative care) as not meeting medical‑necessity standards as described.
Not all source segments contain explicit "not medically necessary" statements. The policy indicates that appendices and external guideline sources provide additional policy components and rationale, and some chunks of the provided document do not restate explicit NMN (not medically necessary) phrasing within those excerpts. Review of Appendix A and the referenced guidelines is therefore required to capture any exclusion language not restated in the main sections.
Objective Tests, Imaging Thresholds, and Metrics
Prior Authorization, Documentation, and Denial Risks
Mandatory P-SOP completion for elective fusion and high‑risk decompressions
The Pre-Surgical Optimization Program (P-SOP) must be completed and documented for all elective spinal fusion procedures and for any elective laminectomy/decompression performed on High-Risk Patients; documentation of P-SOP components and metrics is required for pre-authorization. Waiver only allowed for emergent surgery for acute neurologic deficit, trauma, or tumor.
- P-SOP administered/documented by a licensed provider for ≥ 6 weeks within the 3 months prior to surgery.
- P-SOP components to document include nicotine cessation, pre-habilitation sessions, nutritional/metabolic metrics, psychological/behavioral sessions, and opioid weaning metrics.
Prior authorization and required submission elements
Submit a prior authorization request for level-specific or advanced spinal procedures with all required supporting documentation and appendices; include the P-SOP documentation and other attachments listed in Appendix A to demonstrate medical necessity.
- Include completed P-SOP documentation and metrics (see P-SOP requirements).
- Attach all applicable appendices and referenced documents per Appendix A.
Required conservative management documentation prior to authorization
Document a trial of conservative management for the required duration before authorization: 3–6 months for fusion indications and 6–12 weeks for laminectomy/decompression; include evidence of active physical therapy plus at least one complementary strategy.
- Fusion indications: conservative care documented for 3–6 months (Active PT ≥4–6 weeks plus ≥1 complementary therapy).
- Laminectomy/decompression: conservative care documented for 6–12 weeks (Active PT ≥4–6 weeks plus ≥1 complementary therapy).
Required documentation to include with authorization request
Provide all required documentation listed by the policy to support authorization, including advanced imaging with formal radiology reports current within 6 months and clear clinical–radiologic correlation, and P-SOP engagement evidence (cotinine, PT/CBT counts, opioid taper metrics).
- Advanced imaging (MRI/CT/CT myelogram) of the symptomatic region with formal written radiologist report, generally current within 6 months unless unchanged.
- Clinical–radiologic correlation demonstrating symptoms/exam match imaging findings.
- P-SOP evidence: negative urine cotinine within 7 days (below 100 ng/mL) or alternative testing for NRT users; documentation of PT and CBT/PNE session counts; opioid reduction/cessation metrics.
Attach required appendices and follow pre‑operative requirements (Appendix A)
Include any applicable attachments, resources, and labeled appendices with the authorization submission and follow Appendix A for mandatory patient safety and pre‑operative requirements (P-SOP) and referenced guideline sources.
- Label and include appendices as specified in the APPENDICES section.
- Ensure Appendix A materials (P-SOP components and guideline sources) are attached to support the request.
Denial triggers: imaging–symptom mismatch and excluded procedures
Requests may be denied if imaging does not correlate with the patient's symptoms or examination (for example, mild stenosis or asymptomatic degeneration), or if the requested device/procedure is listed as not medically necessary.
- Not medically necessary procedures (e.g., interspinous/interlaminar devices, lumbar ADR, stem cell/PRP) are denial triggers when requested.
- Imaging that fails to demonstrate the pathology matching clinical presentation can lead to denial.
Risk of denial or delay for incomplete documentation or missing appendices
Incomplete submissions that fail to include required attachments, P-SOP documentation, or the mandatory appendices may result in delays or denial of authorization.
- Omitting P-SOP evidence (metrics, lab tests, session counts) risks incomplete review and potential denial.
- Failure to include Appendix A materials or other labeled appendices may cause denial or processing delays.
Policy Background and Scope
This policy sets clinical and safety criteria for performing spinal laminectomy and fusion, and it emphasizes mandatory pre‑operative optimization for elective cases. Elective spinal fusion (and elective decompression in High‑Risk Patients) requires completion and documentation of a Pre‑Surgical Optimization Program (P‑SOP) with defined components and metrics prior to authorization. The policy also requires objective imaging with clinical–radiologic correlation, defined conservative management durations before surgery, and specified instability and deformity thresholds to support medical necessity, all intended to mitigate perioperative risk and improve patient selection.
Key Definitions and Risk Stratification
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.